Boston Millennia Partners Portfolio Company, Collegium Pharmaceuticals, Announces Successful Completion of Clinical Study

Millennia Portfolio Company, Collegium Pharmaceuticals, announced today the top-line results from its completed Phase I clinical trial for Oxycodone DETERx®, its extended-release, abuse-deterrent, multi-particulate product in a capsule form.